RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Price:
4.03
TRY
2.81%
Market Closed
Market Cap:
₺2B
Cash Flow Statement
Cash Flow Statement
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Currency: TRY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
78
|
96
|
107
|
91
|
127
|
140
|
154
|
272
|
288
|
301
|
249
|
(71)
|
(0)
|
(185)
|
(223)
|
52
|
141
|
430
|
|
| Depreciation & Amortization |
2
|
3
|
3
|
3
|
4
|
5
|
5
|
6
|
23
|
8
|
7
|
18
|
15
|
26
|
20
|
20
|
21
|
17
|
|
| Other Non-Cash Items |
5
|
(10)
|
(18)
|
(18)
|
(115)
|
(193)
|
(234)
|
(301)
|
(201)
|
(206)
|
(216)
|
211
|
126
|
283
|
33
|
(132)
|
(324)
|
(576)
|
|
| Cash Taxes Paid |
8
|
20
|
19
|
15
|
12
|
14
|
17
|
14
|
5
|
3
|
3
|
4
|
4
|
0
|
3
|
0
|
0
|
0
|
|
| Cash Interest Paid |
2
|
4
|
6
|
6
|
5
|
3
|
4
|
13
|
28
|
16
|
14
|
29
|
26
|
39
|
52
|
78
|
102
|
101
|
|
| Change in Working Capital |
(76)
|
(113)
|
(50)
|
(28)
|
52
|
50
|
(19)
|
(23)
|
(191)
|
(47)
|
12
|
(83)
|
(137)
|
(110)
|
(116)
|
(39)
|
52
|
31
|
|
| Cash from Operating Activities |
9
N/A
|
(25)
N/A
|
43
N/A
|
47
+10%
|
69
+45%
|
2
-98%
|
(94)
N/A
|
(45)
+52%
|
(233)
-413%
|
56
N/A
|
53
-4%
|
43
-19%
|
4
-90%
|
14
+222%
|
(286)
N/A
|
(99)
+65%
|
(109)
-11%
|
(98)
+10%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(17)
|
(21)
|
(26)
|
(19)
|
(22)
|
(22)
|
(14)
|
(21)
|
(37)
|
(22)
|
(27)
|
(48)
|
(21)
|
(22)
|
(16)
|
(96)
|
(98)
|
(100)
|
|
| Other Items |
1
|
1
|
3
|
3
|
17
|
26
|
13
|
13
|
(91)
|
40
|
28
|
89
|
(22)
|
(18)
|
182
|
71
|
180
|
286
|
|
| Cash from Investing Activities |
(16)
N/A
|
(19)
-18%
|
(24)
-22%
|
(16)
+33%
|
(5)
+71%
|
4
N/A
|
(1)
N/A
|
(8)
-1 197%
|
(128)
-1 549%
|
18
N/A
|
1
-97%
|
41
+6 745%
|
(44)
N/A
|
(40)
+8%
|
166
N/A
|
(25)
N/A
|
82
N/A
|
186
+128%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
48
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
13
|
30
|
26
|
24
|
32
|
16
|
23
|
30
|
(36)
|
26
|
(17)
|
(99)
|
(119)
|
(124)
|
53
|
154
|
102
|
(13)
|
|
| Other |
(1)
|
(4)
|
(6)
|
(6)
|
(4)
|
(3)
|
(5)
|
(14)
|
23
|
(14)
|
(11)
|
(12)
|
(10)
|
(22)
|
(40)
|
(70)
|
(92)
|
(90)
|
|
| Cash from Financing Activities |
12
N/A
|
26
+116%
|
20
-24%
|
18
-9%
|
76
+322%
|
61
-20%
|
66
+9%
|
64
-4%
|
(14)
N/A
|
12
N/A
|
(28)
N/A
|
(111)
-299%
|
(130)
-17%
|
(146)
-13%
|
13
N/A
|
84
+553%
|
10
-88%
|
(103)
N/A
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
5
N/A
|
(18)
N/A
|
39
N/A
|
50
+26%
|
140
+183%
|
67
-52%
|
(28)
N/A
|
10
N/A
|
(375)
N/A
|
86
N/A
|
26
-70%
|
(27)
N/A
|
(169)
-516%
|
(172)
-2%
|
(108)
+37%
|
(41)
+62%
|
(17)
+57%
|
(16)
+10%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(45)
-512%
|
17
N/A
|
28
+67%
|
47
+67%
|
(20)
N/A
|
(107)
-434%
|
(66)
+39%
|
(270)
-308%
|
34
N/A
|
26
-23%
|
(5)
N/A
|
(17)
-215%
|
(8)
+52%
|
(303)
-3 597%
|
(195)
+35%
|
(208)
-6%
|
(199)
+4%
|
|
Switch to:
Switch to:
See Also
Discover More
